hif minor headwind issu still
question trim est po
re-adjust model hif impact higher
antm underwhelm in-lin ep print higher medic loss ratio
lower expect guidanc appear guid reduct entir
relat health insur fee hif tax larger headwind els
equal real issu recaptur howev commentari
harder reconcil weak feel like new contract
perform better expect would littl upsid ep
past quarter updat model roll est trim
po repres new estimate vs
previous reiter neutral rate show solid growth
consist disappoint leav us see less upsid peer top
ep guid explain away hif impact
call impli adj ep guidanc within rang
 call yesterday guid adj ep
guidanc least delta high end initi rang
explain entir explain intra-year price impact remov
hif hif repeal report mean core
ep remain unchang lift revers
higher make explan less satisfi
fischbeck focu hard squar antm explan
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu higher expect guidanc
call attribut y/i increas shift busi mix analysi
impli explain half impact leav anoth
ep industri factor rise commerci trend
like culprit view overal well-posit grow membership
improv pharmaci structur trend guidanc like ok upsid
near term like limit see stabl trend
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
net dbt
one largest manag care
organ offer
commerci larg small employ medicar
medicaid individu market compani
oper cross shield plan
neutral rate reflect view
posit show lt doubl digit ep growth
given scale new pbm appear
expos potenti trend acceler
peer could limit near term upsid
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
fischbeck focu mix impact
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu higher expect guidanc
call attribut y/i increas shift busi mix analysi
impli explain half impact leav anoth
ep industri factor rise commerci trend
like culprit view overal well-posit grow membership
improv pharmaci structur trend guidanc like ok upsid
near term like limit see stabl trend
commentari doesnt fulli explain delta
main area disappoint guidanc
expect disappoint high end rang rais
guidanc expect addit increas
core basi note guidanc reduct return
hif lower core essenti guidanc
increas especi surpris given trend
year els equal would expect revers year follow
increas compani secur rate reflect trend implement cost
mitig strategi top compani highlight risk adjust boost
higher flu cost impli slightli higher item would
expect repeat make reduct like
examin move piec guidanc struggl
explain move much less fact would expect
higher exchanges/net medicaid
saw pressur larg attribut medicaid rate
inadequaci driven medicaid redetermin essenti state given
increas flexibl reverifi enrol elig combin improv
economi kick peopl larg healthi peopl enrol leav
sicker risk pool howev rate set assum prior risk pool put upward
pressur result compani mco saw
issu degre work state secur appropri rate
tailwind
howev tailwind off-set margin mean revers
exchang busi year signific rate increas exchang
across industri drop far enough compani forc reduc
price order avoid hit floor boost good
news compani guidanc assum normal margin exchang
busi would expect see addit pressur futur issu
howev combin two dynam lower medicaid higher
exchang result net increas
mix shift hard reconcil
attribut y/i increas mix shift compani
grow higher govern product faster commerci product
commerci risk enrol actual go howev use
antm membership growth guidanc hold product constant y/i
actual difficult get impact compani describ
assum govern higher commerci
busi mix shift toward govern chang busi mix
explain half impact y/i non-hif impact
ep like explain industri factor rise
commerci trend like culprit view
tabl even aggress assumpt dont bridg mix shift impact
bridg impact membership shift higher product ex-hif illustr purpos
commerci aso fee premium
commerci aso fee premium
commerci aso fee premium
commerci aso fee premium
note account hif impact tri calcul implic mix shift
trend like rise howev trend guidanc ok
us like reason unexplain elev part
disappoint trend margin rise support
trend tracker signal higher trend sinc first time
disclaim indic /strategi /screen portfolio includ report intend indic metric may use refer purpos
measur perform financi instrument contract otherwis reli upon third parti purpos without prior written consent bofa global research
none indic /strategi /screen creat act benchmark
beg question whether antm trend guidanc vs
aggress put compani risk miss estim view
believ entir reduct trend guidanc like due
new pharmaci contract note also highlight valu base care site
care initi medic manag strategi contributor wouldnt
quantifi given alway work type program
increment seem unlik would see dramat outsiz
benefit leav us pharmaci save like answer
expect save keep pass back
custom sinc much antm aso busi nation account carv
pharmaci dont use appli save risk product
portion aso book take antm risk revenu gross
aso busi risk appli save
number would reduc trend essenc appear us like
tabl ingeniorx save drive trend
unadjust impact trend
carv assumpt
gross addit revenu
tabl ingeniorx save drive trend
adjust impact trend
conclus growth less upsid
overal well-posit grow membership improv pharmaci
structur prefer provid relationship point rebas guidanc
appear reason even reduct howev given
three straight quarter raises/disappoint believ upsid
near term like limit mani peer abl
histori conservat
note histor provid conserv guidanc beat
rais throughout year give us comfort new guidanc
guid weaker expect drive entir hif
announc adjust ep guidanc least impli year
year growth deceler growth saw last year driven
pull forward ingeniorx save repeal hif outlook
estimate consensu howev ep miss vs expect
explain repeal hif caus unexpect intra-year price
headwind includ guidanc hif repeal
report season note benefit
ingeniorx contribut compani continu expect realiz earn
period skew toward
expect oper revenu approxim impli
growth y/i howev note expect commerci risk enrol
flat expect decent aso-enrol growth midpoint
stronger government growth includ expect /-
hif expect lower busi mix shift higher
govern busi ad close meanwhil medic cost trend
expect /- year year signific drop
trend due reduc spend better cost manag ingeniorx rx
migrat final oper cash flow expect greater billion
saw also expect repurchas least
billion worth share
product sold
po base ep premium histor
averag justifi medium-long term opportun mco broadli
govern busi tailwind lower previou estim short term
risk downsid near-term elev cost trend lead less earn
upsid use also legisl risk includ medicar
risk upsid cost trend moder coupl better-than-expect
enrol growth stronger growth medicar advantag enhanc buyback
long-term benefit new pbm
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
